Core Viewpoint - Noah Source Medical Technology Co., Ltd. has completed its angel round financing to promote the development and industrialization of domestic high-end spectral flow cytometry technology, aiming to enhance the domestic life sciences and precision medicine sectors [2]. Group 1: Company Overview - Noah Source Medical focuses on the independent research and production of high-end full-spectrum flow cytometers, aiming to reduce reliance on imported scientific instruments in China [2]. - The company adheres to the principle of "source innovation" to provide high-performance and reliable domestic flow cytometry solutions for research and clinical users [2]. Group 2: Product Offerings - The Lymacyte S full-spectrum flow cytometer features 17 detection channels at 488nm, utilizing innovative spectral collection and analysis technology, designed for ease of use and high performance, catering to the needs of small to medium-sized laboratories [3]. - The product line includes the Lymacyte multi-laser series, which can support up to 50 fluorescent detection channels and facilitate high-dimensional immune phenotype analysis, making it suitable for large research platforms, drug development, and clinical translational research [4].